Randy Taylor

Randy Taylor is a seasoned pharmaceutical professional with extensive experience in oncology and rare disease management. Currently serving as a Rare Disease Oncology Account Manager at Syndax Pharmaceuticals since September 2025, Randy leads market development for Revuforj and Niktimvo, focusing on early market adoption strategies and patient identification programs. Previously, as an Immunology Sales Specialist at Aurinia Pharmaceuticals, Randy was a founding member of the launch team for Lupkynis, achieving top ranking in quota attainment and receiving multiple awards for leadership. Randy's background includes roles at Janssen, where significant market growth was achieved through expertise in oncology therapies, and earlier engagements at Centocor and GSK, where foundational sales strategies were developed. Randy holds a Bachelor of Science in Business Administration and Management from the W. P. Carey School of Business at Arizona State University.